vs
Cooper-Standard Holdings Inc.（CPS）与德康医疗（DXCM）财务数据对比。点击上方公司名可切换其他公司
德康医疗的季度营收约是Cooper-Standard Holdings Inc.的1.9倍（$1.3B vs $672.4M），德康医疗净利率更高（21.2% vs 0.5%，领先20.7%），德康医疗同比增速更快（21.6% vs 1.8%）
库博标准控股是全球领先的汽车零部件供应商，总部位于美国密歇根州诺维。公司主营产品包括橡塑密封件、燃油管、制动管、流体输送软管以及减震系统，目前在全球20个国家开展业务，拥有约3.2万名员工。
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
CPS vs DXCM — 直观对比
营收规模更大
DXCM
是对方的1.9倍
$672.4M
营收增速更快
DXCM
高出19.8%
1.8%
净利率更高
DXCM
高出20.7%
0.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $672.4M | $1.3B |
| 净利润 | $3.3M | $267.3M |
| 毛利率 | 10.4% | 62.9% |
| 营业利润率 | 0.1% | 25.6% |
| 净利率 | 0.5% | 21.2% |
| 营收同比 | 1.8% | 21.6% |
| 净利润同比 | -91.7% | 153.6% |
| 每股收益（稀释后） | $0.19 | $0.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPSDXCM
| Q1 26 | — | $1.3B | ||
| Q4 25 | $672.4M | $1.3B | ||
| Q3 25 | $695.5M | $1.2B | ||
| Q2 25 | $706.0M | $1.2B | ||
| Q1 25 | $667.1M | $1.0B | ||
| Q4 24 | $660.8M | $1.1B | ||
| Q3 24 | — | $994.2M | ||
| Q2 24 | — | $1.0B |
净利润CPSDXCM
| Q1 26 | — | $267.3M | ||
| Q4 25 | $3.3M | $267.3M | ||
| Q3 25 | $-7.6M | $283.8M | ||
| Q2 25 | $-1.4M | $179.8M | ||
| Q1 25 | $1.6M | $105.4M | ||
| Q4 24 | $40.2M | $151.7M | ||
| Q3 24 | — | $134.6M | ||
| Q2 24 | — | $143.5M |
毛利率CPSDXCM
| Q1 26 | — | 62.9% | ||
| Q4 25 | 10.4% | 62.9% | ||
| Q3 25 | 12.5% | 60.5% | ||
| Q2 25 | 13.2% | 59.5% | ||
| Q1 25 | 11.6% | 56.9% | ||
| Q4 24 | 12.4% | 58.9% | ||
| Q3 24 | — | 59.7% | ||
| Q2 24 | — | 62.4% |
营业利润率CPSDXCM
| Q1 26 | — | 25.6% | ||
| Q4 25 | 0.1% | 25.6% | ||
| Q3 25 | 3.8% | 20.1% | ||
| Q2 25 | 5.3% | 18.4% | ||
| Q1 25 | 3.3% | 12.9% | ||
| Q4 24 | 4.8% | 17.0% | ||
| Q3 24 | — | 15.3% | ||
| Q2 24 | — | 15.7% |
净利率CPSDXCM
| Q1 26 | — | 21.2% | ||
| Q4 25 | 0.5% | 21.2% | ||
| Q3 25 | -1.1% | 23.5% | ||
| Q2 25 | -0.2% | 15.5% | ||
| Q1 25 | 0.2% | 10.2% | ||
| Q4 24 | 6.1% | 13.6% | ||
| Q3 24 | — | 13.5% | ||
| Q2 24 | — | 14.3% |
每股收益（稀释后）CPSDXCM
| Q1 26 | — | $0.67 | ||
| Q4 25 | $0.19 | $0.67 | ||
| Q3 25 | $-0.43 | $0.70 | ||
| Q2 25 | $-0.08 | $0.45 | ||
| Q1 25 | $0.09 | $0.27 | ||
| Q4 24 | $2.30 | $0.37 | ||
| Q3 24 | — | $0.34 | ||
| Q2 24 | — | $0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $191.7M | $917.7M |
| 总债务越低越好 | $1.0B | — |
| 股东权益账面价值 | $-83.5M | $2.7B |
| 总资产 | $1.8B | $6.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CPSDXCM
| Q1 26 | — | $917.7M | ||
| Q4 25 | $191.7M | $917.7M | ||
| Q3 25 | $147.6M | $1.8B | ||
| Q2 25 | $121.6M | $1.2B | ||
| Q1 25 | $140.4M | $904.9M | ||
| Q4 24 | $170.0M | $606.1M | ||
| Q3 24 | — | $621.2M | ||
| Q2 24 | — | $939.2M |
总债务CPSDXCM
| Q1 26 | — | — | ||
| Q4 25 | $1.0B | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益CPSDXCM
| Q1 26 | — | $2.7B | ||
| Q4 25 | $-83.5M | $2.7B | ||
| Q3 25 | $-102.3M | $2.7B | ||
| Q2 25 | $-97.6M | $2.6B | ||
| Q1 25 | $-114.7M | $2.3B | ||
| Q4 24 | $-125.8M | $2.1B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $2.4B |
总资产CPSDXCM
| Q1 26 | — | $6.3B | ||
| Q4 25 | $1.8B | $6.3B | ||
| Q3 25 | $1.9B | $7.5B | ||
| Q2 25 | $1.8B | $7.3B | ||
| Q1 25 | $1.8B | $6.8B | ||
| Q4 24 | $1.7B | $6.5B | ||
| Q3 24 | — | $6.4B | ||
| Q2 24 | — | $6.8B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $56.2M | — |
| 自由现金流经营现金流 - 资本支出 | $44.6M | — |
| 自由现金流率自由现金流/营收 | 6.6% | — |
| 资本支出强度资本支出/营收 | 1.7% | — |
| 现金转化率经营现金流/净利润 | 16.90× | — |
| 过去12个月自由现金流最近4个季度 | $16.3M | — |
8季度趋势，按日历期对齐
经营现金流CPSDXCM
| Q1 26 | — | — | ||
| Q4 25 | $56.2M | $294.0M | ||
| Q3 25 | $38.6M | $659.9M | ||
| Q2 25 | $-15.6M | $303.0M | ||
| Q1 25 | $-14.9M | $183.8M | ||
| Q4 24 | $74.7M | $301.4M | ||
| Q3 24 | — | $199.5M | ||
| Q2 24 | — | $279.4M |
自由现金流CPSDXCM
| Q1 26 | — | — | ||
| Q4 25 | $44.6M | $192.1M | ||
| Q3 25 | $27.4M | $579.4M | ||
| Q2 25 | $-23.4M | $208.9M | ||
| Q1 25 | $-32.4M | $96.8M | ||
| Q4 24 | $63.2M | $176.8M | ||
| Q3 24 | — | $88.3M | ||
| Q2 24 | — | $213.3M |
自由现金流率CPSDXCM
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | 15.3% | ||
| Q3 25 | 3.9% | 47.9% | ||
| Q2 25 | -3.3% | 18.1% | ||
| Q1 25 | -4.9% | 9.3% | ||
| Q4 24 | 9.6% | 15.9% | ||
| Q3 24 | — | 8.9% | ||
| Q2 24 | — | 21.2% |
资本支出强度CPSDXCM
| Q1 26 | — | — | ||
| Q4 25 | 1.7% | 8.1% | ||
| Q3 25 | 1.6% | 6.7% | ||
| Q2 25 | 1.1% | 8.1% | ||
| Q1 25 | 2.6% | 8.4% | ||
| Q4 24 | 1.7% | 11.2% | ||
| Q3 24 | — | 11.2% | ||
| Q2 24 | — | 6.6% |
现金转化率CPSDXCM
| Q1 26 | — | — | ||
| Q4 25 | 16.90× | 1.10× | ||
| Q3 25 | — | 2.33× | ||
| Q2 25 | — | 1.69× | ||
| Q1 25 | -9.57× | 1.74× | ||
| Q4 24 | 1.86× | 1.99× | ||
| Q3 24 | — | 1.48× | ||
| Q2 24 | — | 1.95× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CPS
| Sealing Systems | $357.8M | 53% |
| Fluid Handling Systems | $297.1M | 44% |
| Corporate And Other Segment | $17.4M | 3% |
| Commercial | $6.6M | 1% |
DXCM
暂无分部数据
